The effect of Vitis vinifera L. leaves extract on Leishmania infantum

Iranian Journal of Pharmaceutical Research

Volumn 12, Issue 3, 2013, Pages 349-355

  Mansour, Rym ^a   Haouas, Najoua ^b   Kahla Nakbi, Amel Ben ^c   Hammami, Saoussen ^b   Mighri, Zine ^a   Mhenni, Farouk ^a   Babba, Hamouda ^b  

^a Unité of Recherche 12 04   (Tunisia)

^b Laboratoire de Parasitologie   (Tunisia)

^c INSTITUT NATIONAL DES SCIENCES ET TECHNOLOGIES DE LA MER   (Tunisia)

Author keywords

Anthocyanins; Antileishmanial activity; Extraction; Leishmaniasis; Vitis vinifera L.

Indexed keywords

ALCOHOL; ANTHOCYANIN; ANTILEISHMANIAL AGENT; MEGLUMINE ANTIMONATE; VITIS VINIFERA EXTRACT; WATER;

ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; GRAPE; IC 50; LEISHMANIA INFANTUM; LEISHMANIASIS; NONHUMAN; PARASITE VIABILITY; PLANT LEAF; PROMASTIGOTE;

EID: 84883826731     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Aoun K, Jeddi F, Amri F, Ghrab J and Bouratbine A. Actualités épidémiologiques de la leishmaniose viscérale en Tunisie. Méd. Mal. Infect. (2009) 39: 775-779.
2. Faraut-Gambarelli F, Piarroux F, Giusiano B, Marty P, Michel G, Faugère B and Dumon H. in- vitro and in-vivo resistance of Leishmaniainfantumto meglumineantimoniate: a study of 37 strains collected from patients with visceral leishmaniasis. Antimicrob Agents Chemother (1997) 41: 27-830
3. Carrio J, Riera C, Gállego M and Ports M. In-vitro activity of pentavalent antimony derivatives on promastigotes and intracellular amastigotes of Leishmaniainfantum strains from humans and dogs in Spain. Acta. Trop. (2001) 79: 179-180.
4. Belhadj S, Pratlong F, Hammami M, Kallel K, Dedet J and Chaker E. Human cutaneous leishmaniasis due to Leishmania infantum in the Sidi Bourouis focus (Northern Tunisia): epidemiological study and isoenzymatic characterization of the parasites. Acta. Trop. (2003) 85: 83-86.
5. Kallel K, Pratlong F, Belhadj M, Cherif F, Hammami M, Dedet J and Chaker E. La leishmaniose cutanée due à Leishmania infantum MON-24 en Tunisie: extension du foyer vers le centre du paysAnn Trop. Med. Parasitol. (2005) 99: 11-19.
6. Gradonil L, Gramiccia M, Pettoello M, Di Martino L and Nocerino A. A new Leishmaniainfantumenzymatic variant, agent of an urban visceral case unresponsive to drugs. Trans. R. Soc. Trop. Med. Hyg. (1987) 81: 927-8.
7. Gradonil L and Bryceson A. The increase of risk factors for leishmaniasis worldwide. Trans. R. Soc. Trop. Med. Hyg. (2001) 95: 239-43.
8. Lawn S, Aarmstrong M, Chilton D and Whitty C. Electrocardiographic and biochemical adverse effects of sodium stibogluconate during treatment of cutaneous andmucosalleishmaniasis among returned travellers. Trans. R. Soc. Trop. Med. Hyg. (2006) 100: 264-269.
9. Domingo P, Ferrer S and Kolle L. Acute pancreatitis associated with sodium stibogluconate treatment in a patient with Human Immunodefciency Virus. Arch. Intern. Med. (1996) 156: 1029-1032.
10. Sundar S. Drug resistance in Indian visceral leishmaniasis. Trop. Med. Int. Health. (2001) 6: 849-854.
11. Das V and Ranjan A. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar. Nat. Med. J. India. (2005) 18: 131-133.
12. Haouas N, Gorcii M, Chargui N, Aoun K, Bouratbine A, Messaadi A, Masmoudi M, Zili J, Ben Said M, Pratlong F, Dedet J, Mezhoud H, Azaiez R and Babba H. Leishmaniasis in central and southern Tunisia: Current geographical distribution of zymodemes. Parasite (2007) 14: 239-246
13. Bombardelli E, Morazzonni P and Vitisvinifera L. Fitoterapia (1995) 66: 291-317.
14. Baytop T, Bitkiler Ile Tedavi (GeçmişteveBugün). Nobel. Ti{dotless}p. Kitabevleri. Istanbul, (1999) 357-358.
15. Kallel K, Haouas N, Pratlong F, Kaouech E, Belhadj S, Anane S, Dedet J, Babba H and Chaker E. La leishmaniose cutanée due à Leishmania infantum MON-24 en Tunisie: extension du foyer vers le centre du pays. Bull. Soc. Pathol. Exot. (2008) 101: 30-31.
16. Kapoor L. Handbook of Ayurvedic Medicinal Plants. CRC Press, Boca Raton, USA, (1990) 45-56.
17. Felicio J, Santos R and Gonc E. Chemical Constituents from Vitis vinifera (Vitaceae). Sao. Paulo. (2001) 68: 47-50.
18. Grieve A. A Modern Herbal, Dover Books New York. Company, White River Junction, USA (1971) 2-10.
19. Onstad D. Whole Foods Companion: A Guide for Adventurous Cooks, Curious Shoppers & Lovers of Natural Foods. Chelsea Green Publishing (1996).
20. rd ed. Dorling Kindersley Ltd., London (2001) 407-411.
21. rded.Timber Press, Porand, USA (2004) 23-30.
22. Kang J, Lee W, Lee C, Yoon W, Kim N, Lee H, Park H, Han S and Yun J. Improvement of high-fat diet-induced obesity by a mixture of red grape extract, soy isofavone and l-carnitine: Implications in cardiovascular and non-alcoholic fatty liver diseases. Food Chem.Toxicol. (2011) 49: 2453-2458.
23. Orhan N, Aslan M, Orhan D, Ergun F and Erdem Y. In-vivo assessment of antidiabetic and antioxidant activities of grapevine leaves (Vitisvinifera) in diabetic rats. J Ethnopharmacol. (2006) 108: 280-286.
24. Hebash K, Fadel H and Soliman M. Volatile components of grape leaves. J. Islam. Acad. Sc. (1991) 4: 26-28.
25. Nilüfer Orhan, Mustafa Aslan, Didem Deliorman Orhan, Fatma Ergun and ErdemYeşilada. In-vivo assessement of antidiabetic and antioxidant activities of grape vine leaves (vitisvinifera L.) in diabetic rats. J. Ethnopharmacol. (2006) 108: 280-286.
26. Mansour R, Ayed L, Hammami S, Mighri Z, Bakhrouf A and Mhenni F. Propriétés tinctoriales et Activités antibactériennes d'extraits de feuilles de Vitisvinifera L. de TUNISIE. Tunisian J. Med. Plants. Nat. Prod. (2011) 6: 126-132.
27. Jin-Ming K, Lian-Sai C, Ngoh-Khang G, Tet-Fatt C and Brouillard R. Analysis and biological activities of anthocyanins, Phytho. Chimstry (2003) 64: 923-933
28. Ezzili B, Habib J, Darné G and Chemli R. Infuence de la date de prélèvement sur les teneurs en anthocyanes et en éléments minéraux des feuilles du cépage Alicante Bouschet cultivé à El Khengue. Bull OIV, (1997) 70: 795-796.
29. Penchev PI. PhDthesis: Étude des procédés d'extraction et de purifcation de produits bioactifs à partir de plantes par couplage de techniques séparatives à basses et hautes pressions. Toulouse, Toulouse University. (2010) 50-53.
30. Hmamouchi M, Es-Saf N and Essassi E. Oligomeric and polymericproanthocyanidins from Moroccangrapewine (Vitisvinifera) leaves. Fitoterapia (1997) 68: 332-337.
31. Monagas M, Gómez-Cordovés C and Bartolomé B. Evolution of the phenolic content of red wines fromVitisvinifera L. during ageing in bottle. Food Chemistry (2012) 95: 405-412
32. Murphy Cowan M. Plant Products as Antimicrobial Agents. Clinical Microbiol Rev (1999) 12: 564-582.
33. Konczak I and Zhang W. Anthocyanins-More Than Nature's Colours. J. Biomed. Biotec. (2004) 5: 239-240.
34. Aviram M, Fuhrman B. Wine favonoids protect against LDL oxidation and atherosclerosis. Ann. NY. Acad. Sci. (2002) 957: 146-61.
35. Kolodziej H and Kiderlen A. Antileishmanial activity and immune modulatory effects of tannins and related compounds on Leishmania parasitised RAW 264.7 cells. Phyto. Chemistry (2005) 66: 2056-2071.
36. Lewin G, Cojean S, Gupta A, Verma S, Puri K and Loiseau P. In-vitro antileishmanial properties of new favonoids against Leishmaniadonovani. Biomedicine and Preventive Nutrion (2011) 1: 168-171.
37. Nour A, Khalid S, Kaiser M, Brun R, Abdalla W and Schmidt T. The antiprotozoal activity of methylated favonoids from Ageratum conyzoides L. J. Ethno. Pharmacol. (2010) 129: 127-130.
38. Valadares G, Duarte C, Oliveira S, Chávez-Fumagalli A, Martins T, Costa E, João V, Santoro M, Régis C, Tavares A and Coelho A. Leishmanicidal activity of the Agaricusblazei Murill in different Leishmania species. Parasitol. Internat. (2011) 60: 335-544.
39. Ghazanfari T, Hassan M and Khamesipour A. Enhancement of peritoneal macrophage phagocytic activity against L. major by garlic (Allium Sativum) treatment. J. Ethno. Pharmacol. (2006) 103: 333-337.